IINN.NASDAQInspira Technologies Oxy Bhn LTD
20-F/A: Inspira Technologies Files Amendment to 20-F Annual Report, Addressing Auditor Opinion Date
Sentiment:
20-F/A Filing
Inspira Technologies Oxy B.H.N. Ltd. files an amendment to its annual report on Form 20-F solely to update the date of the auditor's opinion, with no changes to the financial statements themselves.
Summary
- Inspira Technologies Oxy B.H.N. Ltd. has filed Amendment No. 1 to its Annual Report on Form 20-F.
- The amendment's sole purpose is to correct the date of the auditor's opinion, which is located on page F-2.
- The audited financial statements for the fiscal years ended December 31, 2024, 2023, and 2022 remain unchanged from the original filing.
- Certifications pursuant to Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002 have been re-executed and re-filed as part of this amendment.
- The company had 24,252,096 ordinary shares outstanding as of December 31, 2024.
Sentiment
Score: 7
Explanation: The document is a routine amendment, so the sentiment is neutral. The company is addressing a minor issue related to the auditor's opinion date.
Key Dates
| Date | Description |
|---|---|
| March 1, 2018 | Date of Shareholder Loan Agreement by and between the Company and Dagi Ben-Noon |
| December 20, 2021 | Filing of Amended and Restated Articles of Association of Inspira Technologies Oxy B.H.N. Ltd. |
| December 20, 2021 | Filing of Inspira Technologies Oxy B.H.N. Ltd. Compensation Policy for Company's Executives |
| December 12, 2021 | The Company terminated its employment agreement with Dr. Udi Nussinovitch |
| December 17, 2021 | Extraordinary General Meeting of Shareholders |
| February 24, 2022 | The Company sued Mr. Nussinovitch for breach good faith and his fiduciary duties |
| March 24, 2022 | The Companys board of directors approved a grant of 536,141 RSUs to employees and a grant of 22,500 RSUs to the Companys advisory board members and an additional consultant. |
| March 24, 2022 | The Companys Board of Directors approved a grant of 29,400 Ordinary Shares options to medical board members |
| April 6, 2022 | The Companys Board of Directors approved a grant of 285,713 fully vested RSUs to an officer. |
| August 8, 2022 | Date of Form of Amendment of Warrant Agreement by and between the Company and American Stock Transfer & Trust Company, LLC |
| November 9, 2022 | Mr. Nussinovitch filed a Statement of Claim against the Company |
| November 8, 2022 | Mr. Nussinovitch filed a Statement of Claim with the regional labor court in Tel Aviv, Israel |
| November 22, 2022 | The Companys Board of Directors approved a grant of 165,000 RSUs to employees. |
| December 27, 2023 | Filing of Form of Securities Purchase Agreement |
| December 27, 2023 | Filing of Form of Ordinary Share Purchase Warrant |
| December 27, 2023 | Filing of Pre-Funded Ordinary Share Purchase Warrant |
| December 26, 2023 | The Company entered into a securities purchase agreement with an institutional investor in a registered direct offering |
| January 22, 2024 | The Companys Board of Directors approved a grant of 320,000 RSUs to employees and a grant of options to purchase 80,000 shares to consultants. |
| January 21, 2024 | A partial hearing about the civil case was held. |
| February 5, 2024 | The Companys Board of Directors approved a grant of 2,277,000 RSUs to officers, a grant of options to purchase 30,000 Ordinary Shares and 90,000 RSUs to directors. |
| March 25, 2024 | Filing of Form 20-F |
| April 1, 2024 | The Company entered into a purchase agreement with two investors in a registered direct offering |
| May 9, 2024 | Filing of Warrant to Purchase Ordinary Shares |
| May 20, 2024 | The Company issued warrant to purchase 220,000 Ordinary Shares to a service provider |
| June 14, 2024 | The Company entered into a purchase agreement with an individual private investor in a registered direct offering |
| June 17, 2024 | Filing of Pre-Funded Ordinary Share Purchase Warrant |
| June 17, 2024 | Filing of Form of Securities Purchase Agreement |
| June 30, 2024 | The Company issued 45,000 Ordinary Shares to an advisor in connection with a consulting service agreement. |
| November 21, 2024 | Warrants expired |
| December 27, 2024 | The Company entered into a purchase agreement with several investors in a private placement financing |
| January 7, 2025 | Mr. Nussinovitch filed a motion to amend his Statement of Claim, requesting to modify the requested relief. |
| January 13, 2025 | A pretrial hearing was held. |
| February 20, 2025 | The Companys Board of Directors approved a grant of 676,000 RSUs to employees and options to purchase an aggregate of 50,000 Ordinary Shares to service providers under the 2019 Equity Incentive Plan. |
| February 20, 2025 | The Companys Board of Directors approved a grant of 550,000 RSUs to certain of its executives. |
| February 20, 2025 | The Companys Board of Directors approved a grant of 1,810,000 RSUs to certain of its executives. |
| March 5, 2025 | Filing of Amended and Restated Inspira Technologies Oxy B.H.N. Ltd. 2019 Equity Incentive Plan |
| March 6, 2025 | These Financial Statements were authorized by the Board of Directors |
| March 10, 2025 | Filing of Description of Securities |
| March 10, 2025 | Filing of Insider Trading Policy |
| March 28, 2025 | Date of report |
Keywords
20-F, amendment, financial statements, auditor's opinion, Inspira Technologies, annual report
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.